Eric Laywell Biomedical Sciences

Slides:

Advertisements

Similar presentations

2. Cannabinoids are provided in vials containing the cannabinoids as a resin diluted in ethanol. These vials are stored at -20ºC. 3. In order to prepare.

Advertisements

Advancing the Development of Pediatric Therapeutics (ADEPT) II: Evaluation of Long-term Neurocognitive Development in Pediatrics U.S. Food and Drug Administration.

1 Biomedical Sciences Public and Environmental Health Regenerative Medicine Translational Research.

Presented By Raymond Huang at 2014 ASCO Annual Meeting

Cancer Nanotechnology: New Opportunities for Targeted Therapies FDA Public Meeting October 10, 2006 Piotr Grodzinski, Ph.D. Director, Nanotechnology for.

 Chemistry 210  By Eugene Z urlich. UWIRIN GIYIMINA.

Evaluating Potential Drug Therapies Mike Shuler Biomedical Engineering.

Phase 1 Clinical Studies First-In-Human (FIH) Pharmacologically-Guided Dose Escalation Jerry M. Collins, Ph.D. Developmental Therapeutics Program Division.

Annual prostate cancer symposium February 23, 2013 The Kimmel Cancer Center, Philadelphia, PA 2nd “ Novel Therapeutic Strategies for Prostate Cancer ”

Magnetic Materials in Medicine: Applications in Diagnosis, Management, and Treatment of Disease Tim St Pierre School of Physics, The University of Western.

Antibody and prodrug therapy of cancer

The Use of a Vesicular Delivery System in the Enhancement of Cisplatin Bioavailability Manal M. Alsaadi, Katharine C. Carter and Alexander B. Mullen Strathclyde.

FDA’s Public Workshop: Innovative Systems for Delivery of Drugs and Biologics: Scientific, Clinical, and Regulatory Challenges Paul Goldfarb, MD, FACS.

Contemporary Science Issues Lesson 6: New medicines Task 1: Testing and using a new drug Timeline cards (4 per A4 page) In pairs, students are required.

WP2 Combined effect of charged particles irradiation and anticancer drugs in cultured human tumor cells (Milano and Roma 3, collaboration with CNAO and.

WP2. Combined effect of charged particles irradiation and anticancer drugs in cultured human tumor cells (Milano and Roma 3, collaboration with CNAO and.

Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer Jing Tian, PhD, Yuangzeng.

Theranostic radiopharmaceuticals for imaging/treatment of cancer

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

From Bench to Clinical Applications: Money Talks

Robert J. Tomko Jr. Biomedical Sciences

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

A Paradigm Shift From One-Size-Fits-All to Tailor-Made Therapy for Metastatic Colorectal Cancer.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Michael Blaber Biomedical Sciences

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Sachs Annual Biotech in Europe Forum

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

cells  tissue  organs  organ systems  organism

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Therapeutic Strategies in COPD Focus on Patient Characteristics and Drug Delivery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Anticoagulants: System-Level Contracting

Advancing the field of drug delivery

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Volume 43, Issue 4, Pages (October 2005)

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

On the Design of Combination Cancer Therapy

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Chloroquine (CQ) improves tumor cell kill when used in combination with vemurafenib and chemotherapy in BRAFV600E-mutant cells. Chloroquine (CQ) improves.

Protracted temozolomide (TMZ) treatment leads to acquired TMZ resistance in glioblastoma (GBM) cells in vivo. Protracted temozolomide (TMZ) treatment leads.

Fig. 1 Concept of study and identification of DRL for cancer cell–based self-targeting therapies. Concept of study and identification of DRL for cancer.

Antitumor effects of celastrol in vitro and in vivo.

Fig. 2. HR estimated by the multivariate analysis for predicting factors associated with longer overall survival using a Cox regression model at the time.

New directions for enhanced 13C imaging of brain cancer.

Quantitative PTEN protein expression is associated with pertuzumab sensitivity in vitro and trastuzumab resistance in vivo. Quantitative PTEN protein expression.

In vivo prophylactic and therapeutic efficacy of C12G6 in mice

Proliferation of TA3-Ha and TA3-St cells in vitro and in vivo.

Parthenolide inhibits tumor promotion and increases p21 expression in vivo. Parthenolide inhibits tumor promotion and increases p21 expression in vivo.

Presentation transcript:

Eric Laywell Biomedical Sciences eric.laywell@med.fsu.edu Using thymidine analogs to treat glioblastoma, particularly in combination with a novel adaptive dosing paradigm (currently supported by NIH). Novel therapeutics and dosing strategies for brain tumors, as well as in vitro and in vivo models. I have experience with methods of assessing neurogenesis in rodent brains, and in a variety of culture models. In addition, I am familiar with mouse models of human cancers, and with novel methods of therapeutic delivery that reduce overall drug burden for the patient.